Gyon Technologies Capital Management’s AstraZeneca AZN Stock Holding History

Gyon Technologies Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,299	Closed	-$1.26M	–	61
2022 Q4	$1.26M	Sell	9,299 -15,648	-63%	-$1.96M	0.47%	69
2022 Q3	$2.74M	Buy	24,947 +14,161	+131%	+$1.8M	0.85%	32
2022 Q2	$1.43M	Buy	10,786 +3,509	+48%	+$460K	0.4%	81
2022 Q1	$966K	Sell	7,277 -1,288	-15%	-$154K	0.68%	43
2021 Q4	$998K	Sell	8,565 -25,901	-75%	-$3.05M	0.18%	157
2021 Q3	$4.14M	Buy	+34,466	New	+$4.01M	1.12%	7
2021 Q2	–	Sell	-2,879	Closed	-$286K	–	356
2021 Q1	$286K	Sell	2,879 -11,243	-80%	-$1.13M	0.12%	287
2020 Q4	$1.41M	Buy	+14,122	New	+$1.5M	0.49%	54

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gyon Technologies Capital Management's AZN Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of AstraZeneca (AZN) in Q1 2023, closing a stake of 9,299 shares — an estimated $1.26M sold.

Gyon Technologies Capital Management first reported a position in AZN in Q4 2020 and held it in 8 quarters. The position peaked at $4.14M in Q3 2021. 1,056 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

Gyon Technologies Capital Management reported no remaining AstraZeneca position as of Q1 2023 after selling out during the quarter.
Gyon Technologies Capital Management sold 9,299 AstraZeneca shares in Q1 2023, an estimated $1.26M.
Gyon Technologies Capital Management first reported a position in AstraZeneca in Q4 2020 and held it in 8 quarters.
Gyon Technologies Capital Management's AstraZeneca position peaked at $4.14M in Q3 2021.
1,056 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.